Evaluation of recombinant human transferrin (DeltaFerrinTM) as an iron chelator in serum-free media for mammalian cell culture

被引:1
|
作者
Joanne Keenan
Dermot Pearson
Lorraine O’Driscoll
Patrick Gammell
Martin Clynes
机构
[1] Dublin City University,National Institute for Cellular Biotechnology
[2] Delta Biotechnology Ltd.,undefined
来源
Cytotechnology | 2006年 / 51卷
关键词
Cell culture; Iron chelator; DeltaFerrin; Recombinant human transferrin; Serum-free media;
D O I
暂无
中图分类号
学科分类号
摘要
DeltaFerrinTM, a yeast-derived recombinant human transferrin produced by Delta Biotechnology Ltd. (Nottingham UK), was found to be a suitable replacement for holo human transferrin in serum-free culture media of the MDCK cell line (chosen because of its transferrin dependence) in short-term screening assays. Long-term subculture was achieved with DeltaFerrinTM supporting growth equivalent to that of holo human transferrin. DeltaFerrinTM and a selection of chemical iron chelators were found in short-term assays to be equivalent to holo human transferrin in supporting growth of MDCK, BHK-21-PPI-C16 and Vero-PPI. In long-term subcultures, however, only DeltaFerrinTM was found to support cell growth in a manner essentially equivalent to holo human transferrin in all three cell lines. For both BHK and Vero variants tested, recombinant preproinsulin production was unaltered by replacing holo human transferrin with DeltaFerrinTM. As such, this is the first report of a recombinant human transferrin produced under animal-free conditions that can act as a universal iron chelator for cells grown in serum-free media (SFM).
引用
收藏
页码:29 / 37
页数:8
相关论文
共 50 条
  • [1] Evaluation of recombinant human transferrin (DeltaFerrin™) as an iron chelator in serum-free media for mammalian cell culture
    Keenan, Joanne
    Pearson, Dermot
    O'Driscoll, Lorraine
    Gammell, Patrick
    Clynes, Martin
    CYTOTECHNOLOGY, 2006, 51 (01) : 29 - 37
  • [2] Evaluation of a Serum-Free Medium for Human Epithelial and Stromal Cell Culture
    Caneparo, Christophe
    Chabaud, Stephane
    Fradette, Julie
    Bolduc, Stephane
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [3] PRODUCTION OF RECOMBINANT PROTEINS IN SERUM-FREE MEDIA
    BRAOD, D
    BORASTON, R
    RHODES, M
    CYTOTECHNOLOGY, 1991, 5 (01) : 47 - 55
  • [4] Insulin-Transferrin-Selenium as a Novel Serum-free Media Supplement for the Culture of Human Amnion Mesenchymal Stem Cells
    Liu, Xiaoyu
    Zhang, Tao
    Wang, Rui
    Shi, Ping
    Pan, Bochen
    Pang, Xining
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2019, 49 (01): : 63 - 71
  • [5] Evaluation of serum-free culture conditions for primary human nasal epithelial cells
    Mattinger, C
    Nyugen, T
    Schäfer, D
    Hörmann, K
    INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2002, 205 (03) : 235 - 238
  • [6] SERUM-FREE CULTURE OF CARCINOMA CELL-LINES
    COLLODI, P
    RAWSON, C
    BARNES, D
    CYTOTECHNOLOGY, 1991, 5 (01) : 31 - 46
  • [7] A SERUM-FREE MEDIUM FOR HYBRIDOMA CELL-CULTURE
    CHEN, ZH
    KE, YZ
    CHEN, YL
    CYTOTECHNOLOGY, 1993, 11 (03) : 169 - 174
  • [8] Tissue engineered cartilage: Utilization of autologous serum and serum-free media for chondrocyte culture
    Kamil, S. H.
    Kojima, K.
    Vacanti, M. P.
    Zaporojan, V.
    Vacanti, C. A.
    Eavey, R. D.
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2007, 71 (01) : 71 - 75
  • [9] Approaches for recombinant human factor IX production in serum-free suspension cultures
    Ferraz do Amaral, Robson Luis
    Bomfim, Aline de Sousa
    de Abreu-Neto, Mario Soares
    Picanco-Castro, Virginia
    de Sousa Russo, Elisa Maria
    Covas, Dimas Tadeu
    Swiech, Kamilla
    BIOTECHNOLOGY LETTERS, 2016, 38 (03) : 385 - 394
  • [10] A high-yielding serum-free, suspension cell culture process to manufacture recombinant adenoviral vectors for gene therapy
    G. Schoofs
    T. J. Monica
    J. Ayala
    J. Horwitz
    T. Montgomery
    G. Roth
    F. J. Castillo
    Cytotechnology, 1998, 28 : 81 - 89